SOX10 and GATA3 in Adenoid Cystic Carcinoma and Polymorphous Adenocarcinoma

24Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Differentiating between adenoid cystic carcinoma (AdCC) and polymorphous adenocarcinoma (PAC) can be difficult on small biopsies and cytologic specimens. As such, further characterization of their immunophenotype may aid in distinction. Previous studies have found AdCC to be SOX10+/GATA3 variable and PAC to be GATA3 negative. SOX10 expression in PAC has, as yet, not been established. We performed GATA3 and SOX10 immunohistochemistry on whole sections of 25 cases each of AdCC and PAC (including both classic PAC and the cribriform variant) to assess whether these markers are of diagnostic utility in distinguishing between these entities. SOX10 was found to be positive in 100% of PAC and AdCC whereas GATA 3 was immunoreactive in 45% of AdCCs and 20% of PAC. While this is the first series to compare SOX10 and GATA3 staining in these two tumor types, their frequent expression and similar staining patterns render them of limited value in discriminating between these neoplasms.

Cite

CITATION STYLE

APA

Adkins, B. D., Geromes, A., Zhang, L. Y., Chernock, R., Kimmelshue, K., Lewis, J., & Ely, K. (2020). SOX10 and GATA3 in Adenoid Cystic Carcinoma and Polymorphous Adenocarcinoma. Head and Neck Pathology, 14(2), 406–411. https://doi.org/10.1007/s12105-019-01046-w

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free